Medical Xpress news
Medical Xpress / TROP2 marks relapse-driving colorectal cancer cells and opens path to targeted treatment
A team led by researchers from the German Cancer Research Center (DKFZ) and the HI-STEM Stem Cell Institute has discovered a promising new approach to treating advanced colorectal cancer. The study, published in Nature, identifies ...
Medical Xpress / Heart risk markers in adults over 40 with obesity increasingly converge with normal BMI levels
Over the last three decades, differences in unhealthy cholesterol levels and blood pressure between older adults with obesity and those with a normal body mass index (BMI) have narrowed or disappeared in several high-income ...
Medical Xpress / Neurobiologists improve symptoms of Huntington's disease with targeted brain stimulation in mice
Huntington's disease is a devastating brain disorder in which decaying nerve cells lead to progressively worsening cognitive and movement abilities. While the genetic mutation responsible for the condition is well known, ...
Medical Xpress / Could creatine help depression? What five clinical trials show so far
Could the same supplement many people take to build muscle also help treat depression?
Medical Xpress / Study identifies new brain targets for individualized epilepsy treatment
Mayo Clinic researchers have created a detailed map of the pulvinar, a deep brain region that could help doctors more precisely target brain stimulation therapies for people with drug-resistant epilepsy.
Medical Xpress / Fatty liver drives a more dangerous form of colorectal cancer spread, study reveals
Researchers at VIB and KU Leuven, with international partners, have uncovered how fatty liver disease can fuel the most aggressive form of metastatic colorectal cancer. The findings, which appear in the journal Nature, not ...
Medical Xpress / Psychedelics not yet ready for clinical use in ADHD treatment, study finds
In recent years, there has been growing interest among adults with ADHD in the practice of microdosing classic psychedelics such as psilocybin and LSD. The internet is full of personal accounts describing improved concentration, ...
Medical Xpress / GLP-1 drugs outperform SGLT-2 drugs for patients with Afib and type 2 diabetes
Individuals with atrial fibrillation (Afib), or irregular heart rhythm, are at increased risk of stroke, chronic kidney disease and heart failure. These risks are significantly exacerbated if a type 2 diabetes diagnosis is ...
Medical Xpress / Many treatments help chronic back pain, but only in the short term
A large-scale analysis by an international research team, led by Bochum University of Applied Sciences, shows that nonsurgical treatments such as massage, exercise therapy or acupuncture for chronic back pain can alleviate ...
Medical Xpress / Malaria vaccine quest narrows as shared parasite targets emerge in liver
Scientists have identified targets on the malaria-causing parasite that could be key to developing a universal vaccine against one of humankind's oldest and deadliest diseases. Researchers from Oregon Health & Science University ...
Medical Xpress / DNA damage can trigger neurons to self-destruct
Over the past decade, researchers at WashU Medicine have established that a molecule called SARM1 is a central trigger in the loss of axons, the vital wiring of the nervous system. Axon loss is characteristic of many neurodegenerative ...
Medical Xpress / AI turns mouse movements into language-like tokens, uncovering autism-related social behavior patterns
An artificial intelligence model capable of reading and interpreting animal behavior like language has been developed by researchers at KAIST. The team created an AI model that learns behavioral data in a manner similar to ...